Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.

By T. André, A. de Gramont, D. Vernerey, B. Chibaudel, F. Bonnetain, Annemilaï Tijeras-Raballand, A. Scriva, T. Hickish, J. Tabernero, J. Van Laethem and 15 more. Journal of Clinical Oncology, 2015

610 citations recorded by the source corpus.

Subfields: Oncology

View Paper: https://www.semanticscholar.org/paper/007a1369f6447108d171d29d6ca6da90da2b7b35